Directors and Advisors
Director and CEO
Mr Saito is the CEO and a Board member of MHM. He was a General Manager of Mitsui's Healthcare Business 1st Department in the Healthcare Business Division and is currently a non-executive Director on the Board of IHH Healthcare Berhad and Acibadem Group. Mr Saito graduated from Keio University with a Bachelor of Political Science, and holds a MBA from Kellogg School of Management Northwestern University.
Mr Hampson is a founder and managing partner of HM3 Partners LLC., a private equity investment and advisory firm. He has been an investor and operator in the healthcare technology and services industry. He was previously a founder, Chairman and the CEO of MED3OOO, one of the largest healthcare management and technology service providers in the US and it was acquired by McKesson Corporation.
Mr. Morita is a General Manager of the Healthcare & Service Business Department at Mitsui Asia Pacific, and a Director of Keimed Pte. Ltd. Previously he was the General Manager of the Consumer Service Business division at Mitsui India. Mr. Morita holds a Bachelor of Commerce degree from Keio University.
Mr. Saito is the CFO of Mitsui Asia Pacific. Prior to that, he was a Deputy General Manager at the Corporate Planning and Strategy Division, and at the Financial Management Advisory Division. Mr. Saito graduated from Tokyo University of Foreign Studies with a Bachelor of Arts.
Mr. Nagahiro is a General Manager of Mitsui’s Healthcare Business 1st Department and alternate director to Koji Nagatomi on the Board of IHH Healthcare Berhad. Prior to that, he was the COO at MIMS Pte. Ltd. Mr. Nagahiro is a Certified Public Accountant and graduated from University of Tokyo with a Bachelor of Arts in Law. He also holds a MBA from Kellogg School of Management, Northwestern University.
Mr. DeSilva is a seasoned business leader with broad based experience rooted in US, Japan, and Asia Pac healthcare markets. He has developed and executed a range of strategic corporate initiatives, novel business solutions, clinical development strategies, digital health solutions, and change management imperatives. His passion for the future of healthcare brings a fresh perspective to MHM.